KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insulet (PODD) Equity Average (2016 - 2026)

Insulet filings provide 15 years of Equity Average readings, the most recent being $1.4 billion for Q4 2025.

  • On a quarterly basis, Equity Average rose 24.45% to $1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a 24.45% increase, with the full-year FY2025 number at $1.4 billion, up 40.25% from a year prior.
  • Equity Average hit $1.4 billion in Q4 2025 for Insulet, up from $1.4 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.4 billion in Q4 2025 to a low of $425.2 million in Q3 2022.
  • Median Equity Average over the past 5 years was $587.6 million (2021), compared with a mean of $781.2 million.
  • The widest YoY moves for Equity Average: up 781.32% in 2021, down 17.38% in 2021.
  • Insulet's Equity Average stood at $527.1 million in 2021, then dropped by 14.21% to $452.2 million in 2022, then skyrocketed by 48.19% to $670.1 million in 2023, then skyrocketed by 73.82% to $1.2 billion in 2024, then rose by 24.45% to $1.4 billion in 2025.
  • The last three reported values for Equity Average were $1.4 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.